Annual FCF
-$31.47 M
+$3.36 M+9.64%
31 December 2023
Summary:
Cardiff Oncology annual free cash flow is currently -$31.47 million, with the most recent change of +$3.36 million (+9.64%) on 31 December 2023. During the last 3 years, it has fallen by -$14.94 million (-90.42%). CRDF annual FCF is now -1529.00% below its all-time high of -$1.93 million, reached on 31 December 2011.CRDF Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$10.46 M
-$1.23 M-13.28%
30 September 2024
Summary:
Cardiff Oncology quarterly free cash flow is currently -$10.46 million, with the most recent change of -$1.23 million (-13.28%) on 30 September 2024. Over the past year, it has dropped by -$2.18 million (-26.40%). CRDF quarterly FCF is now -2561.91% below its all-time high of -$392.80 thousand, reached on 30 September 2011.CRDF Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$34.65 M
-$2.18 M-6.73%
30 September 2024
Summary:
Cardiff Oncology TTM free cash flow is currently -$34.65 million, with the most recent change of -$2.18 million (-6.73%) on 30 September 2024. Over the past year, it has dropped by -$866.00 thousand (-2.56%). CRDF TTM FCF is now -5977.34% below its all-time high of -$570.20 thousand, reached on 31 March 2011.CRDF TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.6% | -26.4% | -2.6% |
| 3 y3 years | -90.4% | -88.0% | -65.6% |
| 5 y5 years | -138.3% | -221.7% | -153.5% |
CRDF Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -90.4% | +9.6% | -88.0% | at low | -65.6% | +0.5% |
| 5 y | 5 years | -138.3% | +9.6% | -221.7% | at low | -159.9% | +0.5% |
| alltime | all time | -1529.0% | +9.6% | -2561.9% | at low | -5977.3% | +0.5% |
Cardiff Oncology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.46 M(+13.3%) | -$34.65 M(+6.7%) |
| June 2024 | - | -$9.23 M(+18.0%) | -$32.47 M(+6.0%) |
| Mar 2024 | - | -$7.82 M(+9.4%) | -$30.62 M(-2.7%) |
| Dec 2023 | -$31.47 M(-9.6%) | -$7.15 M(-13.6%) | -$31.47 M(-6.9%) |
| Sept 2023 | - | -$8.27 M(+12.0%) | -$33.79 M(+1.0%) |
| June 2023 | - | -$7.38 M(-14.8%) | -$33.45 M(+1.1%) |
| Mar 2023 | - | -$8.67 M(-8.4%) | -$33.07 M(-5.0%) |
| Dec 2022 | -$34.83 M(+49.8%) | -$9.46 M(+19.3%) | -$34.83 M(+6.0%) |
| Sept 2022 | - | -$7.93 M(+13.2%) | -$32.86 M(+7.8%) |
| June 2022 | - | -$7.01 M(-32.8%) | -$30.49 M(+9.7%) |
| Mar 2022 | - | -$10.42 M(+39.0%) | -$27.78 M(+19.5%) |
| Dec 2021 | -$23.25 M(+40.7%) | -$7.50 M(+34.8%) | -$23.25 M(+11.1%) |
| Sept 2021 | - | -$5.56 M(+29.3%) | -$20.93 M(+9.9%) |
| June 2021 | - | -$4.30 M(-26.9%) | -$19.05 M(+0.1%) |
| Mar 2021 | - | -$5.88 M(+13.6%) | -$19.04 M(+15.2%) |
| Dec 2020 | -$16.53 M(+23.9%) | -$5.18 M(+40.8%) | -$16.53 M(+13.0%) |
| Sept 2020 | - | -$3.68 M(-14.2%) | -$14.62 M(+3.0%) |
| June 2020 | - | -$4.29 M(+27.2%) | -$14.19 M(+6.4%) |
| Mar 2020 | - | -$3.37 M(+3.0%) | -$13.34 M(+0.1%) |
| Dec 2019 | -$13.34 M(+1.0%) | -$3.28 M(+0.8%) | -$13.34 M(-2.5%) |
| Sept 2019 | - | -$3.25 M(-5.6%) | -$13.67 M(-1.7%) |
| June 2019 | - | -$3.44 M(+2.3%) | -$13.90 M(+1.4%) |
| Mar 2019 | - | -$3.37 M(-6.9%) | -$13.71 M(+3.8%) |
| Dec 2018 | -$13.20 M(-43.5%) | -$3.61 M(+3.8%) | -$13.20 M(+2.5%) |
| Sept 2018 | - | -$3.48 M(+7.0%) | -$12.89 M(-20.0%) |
| June 2018 | - | -$3.25 M(+13.6%) | -$16.12 M(-7.8%) |
| Mar 2018 | - | -$2.86 M(-13.2%) | -$17.47 M(-25.3%) |
| Dec 2017 | -$23.38 M | -$3.30 M(-50.9%) | -$23.38 M(-19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$6.71 M(+45.7%) | -$29.12 M(-1.6%) |
| June 2017 | - | -$4.61 M(-47.5%) | -$29.58 M(-11.4%) |
| Mar 2017 | - | -$8.77 M(-2.9%) | -$33.37 M(+4.7%) |
| Dec 2016 | -$31.86 M(+30.8%) | -$9.03 M(+26.0%) | -$31.86 M(+4.0%) |
| Sept 2016 | - | -$7.17 M(-14.6%) | -$30.63 M(+5.0%) |
| June 2016 | - | -$8.40 M(+15.5%) | -$29.16 M(+9.4%) |
| Mar 2016 | - | -$7.27 M(-6.7%) | -$26.65 M(+9.4%) |
| Dec 2015 | -$24.36 M(+86.1%) | -$7.79 M(+36.7%) | -$24.36 M(+18.5%) |
| Sept 2015 | - | -$5.70 M(-3.1%) | -$20.56 M(+11.9%) |
| June 2015 | - | -$5.89 M(+18.2%) | -$18.37 M(+21.2%) |
| Mar 2015 | - | -$4.98 M(+24.7%) | -$15.15 M(+15.8%) |
| Dec 2014 | -$13.09 M(+64.3%) | -$3.99 M(+13.8%) | -$13.09 M(+18.7%) |
| Sept 2014 | - | -$3.51 M(+31.5%) | -$11.03 M(+12.2%) |
| June 2014 | - | -$2.67 M(-8.5%) | -$9.83 M(+7.3%) |
| Mar 2014 | - | -$2.92 M(+50.9%) | -$9.16 M(+15.0%) |
| Dec 2013 | -$7.97 M(+53.0%) | -$1.93 M(-16.3%) | -$7.97 M(+7.5%) |
| Sept 2013 | - | -$2.31 M(+15.3%) | -$7.41 M(+12.4%) |
| June 2013 | - | -$2.00 M(+16.3%) | -$6.59 M(+11.2%) |
| Mar 2013 | - | -$1.72 M(+25.0%) | -$5.93 M(+13.8%) |
| Dec 2012 | -$5.21 M(+169.6%) | -$1.38 M(-7.5%) | -$5.21 M(+19.7%) |
| Sept 2012 | - | -$1.49 M(+11.1%) | -$4.35 M(+33.7%) |
| June 2012 | - | -$1.34 M(+33.5%) | -$3.26 M(+37.7%) |
| Mar 2012 | - | -$1.00 M(+92.7%) | -$2.36 M(+22.4%) |
| Dec 2011 | -$1.93 M(-8.7%) | -$520.60 K(+32.5%) | -$1.93 M(+36.9%) |
| Sept 2011 | - | -$392.80 K(-12.4%) | -$1.41 M(+38.6%) |
| June 2011 | - | -$448.20 K(-21.4%) | -$1.02 M(+78.6%) |
| Mar 2011 | - | -$570.20 K | -$570.20 K |
| Dec 2010 | -$2.12 M | - | - |
FAQ
- What is Cardiff Oncology annual free cash flow?
- What is the all time high annual FCF for Cardiff Oncology?
- What is Cardiff Oncology annual FCF year-on-year change?
- What is Cardiff Oncology quarterly free cash flow?
- What is the all time high quarterly FCF for Cardiff Oncology?
- What is Cardiff Oncology quarterly FCF year-on-year change?
- What is Cardiff Oncology TTM free cash flow?
- What is the all time high TTM FCF for Cardiff Oncology?
- What is Cardiff Oncology TTM FCF year-on-year change?
What is Cardiff Oncology annual free cash flow?
The current annual FCF of CRDF is -$31.47 M
What is the all time high annual FCF for Cardiff Oncology?
Cardiff Oncology all-time high annual free cash flow is -$1.93 M
What is Cardiff Oncology annual FCF year-on-year change?
Over the past year, CRDF annual free cash flow has changed by +$3.36 M (+9.64%)
What is Cardiff Oncology quarterly free cash flow?
The current quarterly FCF of CRDF is -$10.46 M
What is the all time high quarterly FCF for Cardiff Oncology?
Cardiff Oncology all-time high quarterly free cash flow is -$392.80 K
What is Cardiff Oncology quarterly FCF year-on-year change?
Over the past year, CRDF quarterly free cash flow has changed by -$2.18 M (-26.40%)
What is Cardiff Oncology TTM free cash flow?
The current TTM FCF of CRDF is -$34.65 M
What is the all time high TTM FCF for Cardiff Oncology?
Cardiff Oncology all-time high TTM free cash flow is -$570.20 K
What is Cardiff Oncology TTM FCF year-on-year change?
Over the past year, CRDF TTM free cash flow has changed by -$866.00 K (-2.56%)